Title for MeetingAbstracts

Alphabetical listing of titles

• Improved uptake rates of Antiretroviral Therapy among hospitalized HIV + patients would significantly reduce readmissions.
• Improved Western blot for typing HIV-1 and HIV-2 infections.
• Improvement and rationalization of documents production about AIDS on French Ministry for health's initiative.
• Improvement in acceptance of HIV testing among pregnant women following the introduction of a program to prevent mother-to-child HIV transmission (MTCT) in Botswana.
• Improvement in CD4 cell diversity during 7-month trial of hydroxyurea in combination with ddI or ddI and d4T.
• Improvement in CD4 T-cell counts despite virologic treatment failure: role of thymic output.
• Improvement in Cost Management and Adherence to Infectious Diseases Society of America (IDSA) 2000 Guidelines in Patients with Community-Acquired Pneumonia (CAP).
• Improvement in diagnosis of visceral Kaposi-sarcoma by endoscopic ultrasound (EUS).
• Improvement in dyslipidemias and continued virological suppression after substitution of PI or NNRTI with tenofovir (TDF) among patients receiving HAART.
• Improvement in Functional Status Following Total Joint Replacement Surgery.
• Improvement in hyperlipidemia following switch of antiretroviral (ARV) therapy to an atazanavir-based HAART regimen: Experience from the U.S. Atazanavir Early Access Program (EAP).
• Improvement in immune status in wasting AIDS patient by providing muscle and immune tissue-specific nutrition.
• Improvement in psychological function in HIV+ IVDU population receiving outpatient psychiatric care.
• Improvement in quality of life before and after lung transplantation in patients with emphysema compared to other indications.
• Improvement in sexual drive and a falling viral load are associated with adherence to anti-retroviral therapy.
• Improvement in survival rates and quality of life, as a result of integral attention in a secondary care hospital in Guatemala City.
• Improvement in T-cell receptor BV perturbations following combination therapy with indinavir and nucleoside RT inhibitors.
• Improvement in T4 level and decrease in opportunistic infections and lymphomas (OI/L) in ARC/pre-ARC patients (T4= 60-300) receiving ampligen compared to placebo.
• Improvement in the Timing of Perioperative Antimicrobial Prophylaxis (PAP) when Administered upon Induction of Anesthesia.
• Improvement in Virologic, Immunologic, and Clinical Outcomes in Clinical Practice from 1996 to 2002.
• Improvement Leaps in the Quality of Managed Care.
• Improvement of adherence in severe non-adherent patients after the intervention of a treatment adherence counsellor.
• Improvement of anti-HIV-2 reactivity of Vironostika anti-HTLV-III.
• Improvement of availability and integration of international scientific information for the German Health Care System: first steps.
• Improvement of CD4+ T cell function positively influences HIV-1-specific CD8+ T cell responses during HAART.
• Improvement of CD4+ T cell receptor repertoire after HAART.
• Improvement of CD4, but not CD8, TCR BV repertoire after HAART.
• Improvement of cytokine production in bone marrow of HIV-infected subjects during HAART.
• Improvement of depression and anxiety trought a psychotherapy program for HIV-infected patients in a public mental health setting.
• Improvement of immune functions in HIV-infected patients with discordant response to antiretroviral therapy.